2018
DOI: 10.1007/s00270-018-1932-1
|View full text |Cite
|
Sign up to set email alerts
|

Radiographic Local Tumor Control and Pain Palliation of Sarcoma Metastases within the Musculoskeletal System with Percutaneous Thermal Ablation

Abstract: Level 4, Retrospective Review.

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1
1
1
1

Citation Types

0
12
0

Year Published

2018
2018
2023
2023

Publication Types

Select...
7
3

Relationship

1
9

Authors

Journals

citations
Cited by 24 publications
(12 citation statements)
references
References 29 publications
0
12
0
Order By: Relevance
“…A retrospective analysis by Vaswani et al [ 79 ] of 64 bone metastases from sarcoma in 41 patients treated with ablation between December 2011 and August 2016 was performed. Two subgroups were treated: oligometastatic disease ( n = 13) and extensively metastatic disease ( n = 51).…”
Section: Literature Search Strategy and Results—interventional Strate...mentioning
confidence: 99%
“…A retrospective analysis by Vaswani et al [ 79 ] of 64 bone metastases from sarcoma in 41 patients treated with ablation between December 2011 and August 2016 was performed. Two subgroups were treated: oligometastatic disease ( n = 13) and extensively metastatic disease ( n = 51).…”
Section: Literature Search Strategy and Results—interventional Strate...mentioning
confidence: 99%
“…Within the given limits of the absence of a distinction among the type of ablative technique used, the numerical pain-rating scale at 32 months of follow-up was 2 ± 2 vs. 5 ± 1 at the baseline ( p < 0.001) and 3/7 metastases (43%) treated for local tumor control showed progression during follow-up, suggesting that percutaneous ablation allows significant long-lasting pain control, but sub-optimal LTC. Similarly, Vaswani et al [ 101 ] evaluated the effectiveness of RFA and CA in achieving local tumor control and pain palliation of sarcoma metastases in 64 patients, of which 13/64 with oligometastatic disease and 51/64 with widespread metastases. Thirty-one patients underwent CA, while 33 RFA and 27 ablated tumors were treated with adjunctive cementoplasty.…”
Section: Cryoablationmentioning
confidence: 99%
“…54 In clinical practice, we recommend ablation of the entire volume of hyperintensity on fluid-sensitive and contrastenhanced MRI sequences plus ablation of at least an additional 3-mm margin to account for microscopic tumor spread and support improved patient outcomes. 55,56 Disadvantages of RFA include CT-occult ablation zone, heat sink effect particularly with hypervascular metastases, relative ineffectiveness for the treatment of osteoblastic tumors, relative contraindication for use of monopolar electrodes in patients with metallic implants and pacemakers due to risk of skin thermal injury and pacemaker dysfunction, intraprocedural pain, and, at times, increased pain during the immediate postablation period. 10,12,13,21,22 In a systematic review and meta-analysis for effectiveness of RFA (combined with cementation) for the treatment of painful osseous metastases comprising 426 patients (14 studies), investigators demonstrated statistically significant pain palliation following RFA.…”
Section: Radiofrequency Ablationmentioning
confidence: 99%